[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19

N Engl J Med. 2022 Feb 10;386(6):592-593. doi: 10.1056/NEJMe2117814. Epub 2021 Dec 16.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19*
  • Cytidine / analogs & derivatives
  • Humans
  • Hydroxylamines
  • SARS-CoV-2

Substances

  • Hydroxylamines
  • Cytidine
  • molnupiravir